531 related articles for article (PubMed ID: 3338471)
1. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
2. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
[TBL] [Abstract][Full Text] [Related]
3. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
[TBL] [Abstract][Full Text] [Related]
4. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
Coller BS; Peerschke EI; Scudder LE; Sullivan CA
J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation.
Boukerche H; Ruchaud-Sparagano MH; Rouen C; Brochier J; Kaplan C; McGregor JL
Br J Haematol; 1996 Feb; 92(2):442-51. PubMed ID: 8603015
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.
Aiken ML; Ginsberg MH; Plow EF
J Clin Invest; 1986 Dec; 78(6):1713-6. PubMed ID: 3782477
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay.
Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT
Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944
[TBL] [Abstract][Full Text] [Related]
9. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
[TBL] [Abstract][Full Text] [Related]
10. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.
Ruggeri ZM; Bader R; de Marco L
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6038-41. PubMed ID: 6310559
[TBL] [Abstract][Full Text] [Related]
11. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.
Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF
J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841
[TBL] [Abstract][Full Text] [Related]
12. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin promotes platelet aggregation.
Tuszynski GP; Rothman VL; Murphy A; Siegler K; Knudsen KA
Blood; 1988 Jul; 72(1):109-15. PubMed ID: 3390605
[TBL] [Abstract][Full Text] [Related]
14. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against platelet membrane glycoproteins. II. Influence on ADP- and collagen-induced platelet aggregation, crossed immunoelectrophoresis studies and relevance to Glanzmann's thrombasthenia.
Jenkins CS; Ali-Briggs EF; Clemetson KJ
Br J Haematol; 1981 Nov; 49(3):439-47. PubMed ID: 6457625
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
17. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
[TBL] [Abstract][Full Text] [Related]
18. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE
Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
[TBL] [Abstract][Full Text] [Related]
20. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]